Eyeonix AIQ, Inc.
Eyeonix AIQ, Inc., identified in its business description as Fast Casual Concepts, Inc., focuses on marketing services through GDS Lumina, Inc. It serves fast-casual restaurants and related businesses, as well as clients in other sectors, with growing opportunities in the auto industry. Its services include digital marketing such as SEO, pay-per-click advertising and email campaigns; brand strategy; social media management; content creation; and analytics and reporting. The company aims to earn marketing and advertising revenue by combining ready-made products with client relationships and providing services to businesses. It is developing integrated marketing products for analyzing and storing data, with planned integration into certain CRM and Dealer Management Programs. The company has divested its restaurant operations and CK Distribution. Its corporate offices are in Florida and Pennsylvania, where it occupies approximately 1,500 square feet in Pennsylvania.
No enriched coverage for $EAIQ in the last 7 days.
No SEC Form 4 filings for $EAIQ in the last 30 days.
See all $EAIQ insider activity →Eyeonix AIQ reported 3Q 2026 revenue of $27.9K, up 6.9% YoY, but swung to a loss due to higher operating expenses. Digital marketing sales increased, but the company expects continued losses and may need additional financing. According to the filing, expenses rose to $43.5K from $25.7K.
Eyeonix AIQ plans to acquire COMMAND HEALGRID source code from Eyeonix Greece via its subsidiary Eyeonix MedAIQ, issuing 30.6 million shares as consideration. The deal, expected to close in 2026, will transfer all rights and development responsibilities to Eyeonix MedAIQ.
Eyeonix AIQ, Inc. (EAIQ) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On October 30, 2026, Eyeonix MedAIQ, Inc., a Wyoming corporation and wholly owned subsidiary of Eyeonix AIQ, Inc. (the “Company”), entered into a Memorandum of Understanding (the “MOU”) with Eyeonix S.A., a company organized under the laws of Greece (“Eyeo
Recent EAIQ coverage spans mergers & acquisitions, earnings and financial news.
Eyeonix AIQ reported 3Q 2026 revenue of $27.9K, up 6.9% YoY, but swung to a loss due to higher operating expenses. Digital marketing sales increased, but the company expects continued losses and may need additional financing. According to the filing, expenses rose to $43.5K from $25.7K.
The share issuance will dilute existing shareholders and may pressure the stock lower pending deal completion.
The proposed share issuance will dilute existing shareholders and signals a strategic expansion into the COMMAND HEALGRID asset.
Board appointments are unlikely to move the stock in the short term.
Board expansion with two new directors; no immediate financial impact disclosed.
AlphAI scores every news story that mentions EAIQ with an AI model for sentiment and relevance, and aggregates insider trades from Eyeonix AIQ, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Eyeonix AIQ reported 3Q 2026 revenue of $27.9K, up 6.9% YoY, but swung to a loss due to higher operating expenses. Digital marketing sales increased, but the company expects continued losses and may need additional financing. According to the filing, expenses rose to $43.5K from $25.7K.
Eyeonix AIQ plans to acquire COMMAND HEALGRID source code from Eyeonix Greece via its subsidiary Eyeonix MedAIQ, issuing 30.6 million shares as consideration. The deal, expected to close in 2026, will transfer all rights and development responsibilities to Eyeonix MedAIQ.
Eyeonix AIQ, Inc. (EAIQ) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On October 30, 2026, Eyeonix MedAIQ, Inc., a Wyoming corporation and wholly owned subsidiary of Eyeonix AIQ, Inc. (the “Company”), entered into a Memorandum of Understanding (the “MOU”) with Eyeonix S.A., a company organized under the laws of Greece (“Eyeo
Eyeonix AIQ (EAIQ) announced the addition of Dr. Rohit Chitale and Dr. Grigoris Gerotziafas to its board of directors, effective October 16, 2026. The company did not disclose reasons or committee changes.
Eyeonix AIQ, Inc. (EAIQ) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 16, 2026 The Company added Dr. Rohit Chitale and Dr. Grigoris Gerotziafas to the board of directors in an Extrao
